A detailed history of Old Point Trust & Financial Services N A transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Old Point Trust & Financial Services N A holds 17,351 shares of BMY stock, worth $772,813. This represents 0.25% of its overall portfolio holdings.

Number of Shares
17,351
Previous 16,301 6.44%
Holding current value
$772,813
Previous $754,000 3.71%
% of portfolio
0.25%
Previous 0.27%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 08, 2025

BUY
$43.31 - $48.98 $45,475 - $51,429
1,050 Added 6.44%
17,351 $782,000
Q2 2025

Jul 18, 2025

BUY
$44.12 - $59.6 $63,532 - $85,824
1,440 Added 9.69%
16,301 $754,000
Q1 2025

May 13, 2025

SELL
$53.9 - $63.11 $70,070 - $82,043
-1,300 Reduced 8.04%
14,861 $906,000
Q4 2024

Feb 11, 2025

SELL
$51.92 - $59.94 $10,384 - $11,988
-200 Reduced 1.22%
16,161 $914,000
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $94,390 - $123,165
2,380 Added 17.02%
16,361 $846,000
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $71,242 - $93,792
1,770 Added 14.5%
13,981 $580,000
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $320,506 - $363,392
6,680 Added 120.77%
12,211 $662,000
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $268,142 - $319,968
5,531 New
5,531 $283,000
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $69,189 - $76,823
1,086 New
1,086 $69,000
Q4 2018

Jan 28, 2019

SELL
$48.76 - $63.23 $184,117 - $238,756
-3,776 Closed
0 $0
Q1 2018

Apr 26, 2018

SELL
$59.92 - $68.98 $41,944 - $48,286
-700 Reduced 15.64%
3,776 $239,000
Q3 2017

Oct 24, 2017

BUY
$55.23 - $63.74 $247,209 - $285,300
4,476
4,476 $285,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $94.7B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Old Point Trust & Financial Services N A Portfolio

Follow Old Point Trust & Financial Services N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Point Trust & Financial Services N A, based on Form 13F filings with the SEC.

News

Stay updated on Old Point Trust & Financial Services N A with notifications on news.